• Review current state of the knowledge pertaining to colorectal cancer (CRC), including risk factors, screening guidelines, pathophysiology and staging, and nationally accepted standards of practice for patient management
• Identify clinical practice implications of emerging clinical trial data relevant to CRC
• Outline approaches to facilitating nurse-physician-pharmacist collaboration in the incorporation of evidence-based interventions into individualized patient care plans
• Using a case study approach, formulate individualized patient care and education plans that
  • Incorporate emerging clinical trial data relevant to therapeutic regimens for treatment and toxicity management
  • Integrate strategies to assist patients in meeting the challenges of cancer survivorship
  • Address unique clinical issues faced by special patient populations (ie, the elderly, those with liver metastases)

Continuing Education
Statement of Credit—Participants who successfully complete this activity (including completion and submission of the evaluation form) will be issued a statement of credit via e-mail or US mail within 4 weeks.

 Nurses. This activity for 1.4 contact hours is provided by the Meniscus Educational Institute.

The Meniscus Educational Institute is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
 
Accreditation refers to recognition of educational activities only and does not imply approval or endorsement by the Meniscus Educational Institute or the American Nurses Credentialing Center’s Commission on Accreditation of any product mentioned.

Provider approved by the California Board of Registered Nursing, Provider No. 13164, for 1.4 contact hours.

Pharmacists. This educational activity is sponsored by the Meniscus Educational Institute. The Meniscus Educational Institute is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. The ACPE Universal Activity Number assigned to this program, for 1.4 contact hours (0.14 CEUs), is 429-999-09-003-H01-P.

ANCC Accreditation Feedback Line

1-866-262-9730

The Accreditation Program of the American Nurses Credentialing Center is interested in the opinions and perspectives of the participants in accredited continuing nursing education activities, particularly perspectives related to the presence of perceived bias* in an activity. For this reason, we provide a toll-free telephone number, which participants may call at any time to tell us about

• Any noted bias or conflict of interest in the education
• Any concerns, compliments, or opinions
• A great experience
• An unpleasant experience
• Your thoughts on the process

Just call and tell us!

1-866-262-9730

*Bias is defined as preferential influence that causes a distortion of opinion or facts. Commercial bias may occur when an educational activity promotes one or more product(s) (drugs, devices, services, software, hardware, etc). This definition is not all inclusive, and participants may use their own interpretation in deciding whether a presentation is biased.

NOTE: statements of commercial support and/or conflict of interest disclosures do not represent bias. Such statements inform the learner that the provider has implemented a mechanism to identify and resolve all conflicts of interest prior to delivery of the educational material.

Financial Disclosures
All individuals in positions to control the content of this program (eg, planners, faculty, content reviewers) are expected to disclose all financial relationships with commercial interests that may have a direct bearing on the subject matter of this continuing education activity. Participants have the responsibility to assess the impact (if any) of the disclosed information on the educational value of the activity. All faculty have been offered a modest honorarium from the accredited provider for their participation in this activity.

Constance Engelking, RN, MS, OCN, has nothing to disclose.

The Meniscus Educational Institute staff has nothing to disclose.

Product Disclosures

Reflecting standard oncology practice, which often requires uses and dosages for therapeutic products that have not been approved by the US Food and Drug Administration, this educational activity includes information about many drugs. All faculty participating in continuing education activities are expected to disclose the approved or investigational status (related to the subject matter of this activity-colorectal cancer) of all products and devices under discussion. This information, as of the time of posting, is summarized briefly in the table here.  In addition, primary references and full prescribing information should be consulted for complete information. Clinicians have the professional responsibility to ensure that drugs are prescribed and used appropriately, based on their own clinical judgment and accepted standards of care.
There is no fee for participating in this activity.

Disclaimer
This activity has been designed to provide continuing education that is focused on specific objectives. In selecting educational activities clinicians should pay special attention to the relevance of those objectives and the application to their particular needs. The intent of all Meniscus Educational Institute educational opportunities is to provide learning that will improve patient care. Clinicians are encouraged to reflect on this activity and its applicability to their own patient population.

The opinions expressed in this activity are those of the faculty and reviewers and do not represent an endorsement by MEI or the companies providing educational grant support of any specific therapeutics or approaches to diagnosis or patient management.

Resources to download:

• Slide presentation 
• Additional resources, including:
  • Abbreviations list
  • Complete slide set (includes supplemental slides not included in Virtual Lecture)
  • Reference list
  • Key Internet resources
  • Treatment algorithms for cancer treatment–induced diarrhea and chemotherapy-induced peripheral neuropathy
• Chemotherapeutic Regimens

Instructions for Completion
To successfully complete this activity and receive continuing education credit, you must review the entire video lecture, score at least 70% on the learning assessment, and complete the evaluation form. You can access the learning assessment and evaluation form by selecting the link below. If you provide your e-mail address, you will receive an immediate e-mail notification with a link to your printable statement of credit.

Click to register and submit your evaluation form online.